Cytokine gene polymorphisms in idiopathic pulmonary fibrosis

Internal Medicine Journal

Volumn 34, Issue 3, 2004, Pages 126-129

  Riha, R L ^a   Yang, I A ^a,b   Rabnott, G C ^a   Tunnicliffe, A M ^a   Fong, K M ^a   Zimmerman, P V ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cytokine gene polymorphism; Genotype; Interstitial lung disease; TNF

Indexed keywords

ADENINE; ARGININE; CYTOKINE; CYTOSINE; DNA; GUANINE; INTERLEUKIN 1; INTERLEUKIN 6; PROLINE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ALLELE; ARTICLE; ASSOCIATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEALTH STATUS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IDIOPATHIC DISEASE; INTRON; LUNG FIBROSIS; MALE; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TANDEM REPEAT;

AGED; CASE-CONTROL STUDIES; CYTOKINES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PULMONARY FIBROSIS; QUEENSLAND; SIALOGLYCOPROTEINS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1942473160     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1444-0903.2004.00503.x     Document Type: Article

References (21)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Grit Care Med 2000; 161: 646-64.
2. Coker RJ, Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur Resp J 1998; 11: 1218-21.
3. Pan LH, Ohtani H, Yamauchi K, Nagura H. Co-expression of TNF-a and IL-1b in human acute pulmonary fibrotic diseases: an immunohistochemical analysis. Pathol Int 1996; 46: 91-9.
4. Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C et al. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-a gene polymorphisms. Am J Respir Crit Care 2000; 162: 755-8.
5. Pantelidis P, Fanning GC, Wells AU, Welsh KI, Du Bois RM. Analysis of tumor necrosis factor-a, lymphotoxin-a, tumor necrosis factor receptor II and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Resp Crit Care Med 2001; 163: 1432-6.
6. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS) -stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-6.
7. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403-4.
8. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303-10.
9. Hurme M, Helminen M. Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes. Scand J Infect Dis 1998; 30: 447-9.
10. Olomolaiye O, Wood NA, Bidwell JL. A novel NlaIII polymorphism in the human IL-6 promoter. Eur J Immunogenet 1998; 25: 267.
11. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-76.
12. Ng Man Kwong G, Hubbard R, Hall I, Johnston I, Britton J, Whyte MKB et al. Lack of an association of functional interleukin-6 and interleukin-10 polymorphisms with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1999; 161: 251.
13. Lympany PA, Avila JJ, Mullighan C, Marshall S, Welsh KI, du Bois RM. Rapid genotyping of transforming growth factor beta1 gene polymorphisms in a UK Caucasoid control population using the polymerase chain reaction and sequence-specific primers. Tissue Antigens 1998; 52: 573-8.
14. El-Gamel A, Awad MR, Hasleton PS, Yonan NA, Hutchinson JA, Campbell CS et al. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. J Heart Lung Transplant 1999; 18: 517-23.
15. Riha RL, Duhig EE, Clarke BE, Steele RH, Slaughter RE, Zimmerman PV. Survival of patients with biopsy-proven usual interstitial pneumonia and non-specific interstitial pneumonia. Eur Resp J 2002; 19: 1114-8.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16: 1215.
17. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG et al. Novel genetic association between ulcerative colitis and the anti- inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-42.
18. Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) 1998; 95: 659-67.
19. Huang SL, Su CH, Chang SC. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1436-9.
20. Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Resp Crit Care Med 2002; 165: 148-51.
21. Coker RK, Laurent GJ, Jeffery PK, du Bois RM, Black CM, McAnulty RJ. Localisation of transforming growth factor b1 and b3 mRNA transcripts in normal and fibrotic human lung. Thorax 2001; 56: 549-56.